Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs

Tsutomu Suzuki1, Asuteka Nagao, Takeo Suzuki

  • 1Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo, Tokyo, Japan. ts@chembio.t.u-tokyo.ac.jp

Insights

Mitochondrial diseases stem from faulty mitochondrial DNA. Taurine modification defects in mitochondrial tRNAs impair protein synthesis, revealing a novel RNA modification disorder as a cause of these conditions.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Mitochondrial diseases arise from mitochondrial DNA mutations causing dysfunction.
  • Pathogenic mutations often affect mitochondrial transfer RNAs (mt tRNAs), leading to impaired function.
  • Previous research linked specific mutations to mitochondrial diseases like MELAS and MERRF.

Purpose of the Study:

  • To investigate the molecular pathogenesis of mitochondrial diseases caused by mt tRNA mutations.
  • To determine the role of posttranscriptional taurine modification in mutant mt tRNAs.
  • To establish the link between impaired RNA modification and mitochondrial dysfunction.

Main Methods:

  • Analysis of mt tRNAs isolated from patient-derived cells.
  • Assessment of posttranscriptional taurine modification at the anticodon wobble uridine.
  • Evaluation of protein synthesis efficiency in relation to mt tRNA function.

Main Results:

  • Absence of taurine modification was observed in mutant mt tRNAs from MELAS and MERRF patients.
  • Defective taurine modification leads to decoding errors of cognate codons.
  • Impaired mt tRNA function results in a deficiency in mitochondrial protein synthesis.

Conclusions:

  • The study identifies a deficiency in taurine modification of mt tRNAs as a primary cause of mitochondrial dysfunction.
  • This represents the first evidence of molecular pathogenesis linked to an RNA modification disorder.
  • Restoring taurine modification could be a therapeutic strategy for mitochondrial diseases.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...